AltPep (Series A)
Funding Details
Awarder
Inbox
Date Award
January 15, 2021
Vertical
Biomedical Technology
Funding Amount
$23,150,000
Company Info
Organizations Involved
Eli Lilly and Company, Partners Investment Co., Senator Investment Group
Founders
Valerie Daggett
Market
Alzheimer's Disease and CNS-mediated disorders
Location
Mercer Island, WA, USA
Coinvestors
Alexandria Venture Investments, Matrix Capital Management
Company Description

AltPep provides a novel approach for tackling amyloid diseases, with diagnostic, therapeutic and anti-biofilm applications.